Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
11/2003
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649609 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds
11/13/2003WO2003093223A1 Biphenyl carboxamides
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/12/2003CN1127470C Novel tetralone or benzopyranone derivatives and process for producing same
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6645951 Benzopyran or thiobenzopyran derivatives
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091212A1 Cinnamic acid amides
11/06/2003WO2002076979A8 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
11/06/2003WO2002070509A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003US20030207898 Sulfides such as N-(2-(((6- chloro-1,3-benzodioxol-5-yl)methyl )thio)phenyl)thiophene-2-carboxamide used for controlling metabolism of lipids and prophylaxis of diabetes, Alzheimers disease, atherosclerosis, dyslipidemia and genetic disorders
11/06/2003US20030207871 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/05/2003EP1358184A1 Substituted alkylamine derivatives and methods of use
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1358154A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/05/2003EP1357905A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/05/2003EP1068194B1 Pde iv inhibiting pyridine derivatives
11/05/2003CN1453275A Novel indodyl oxazole compound and its prepn. and application
11/04/2003US6642383 Of the class 3,3,5,5-tetramethyl-2-oxo-1,4-piperazine, polymers thereof; stabilizers for thermoplastic organic polymers, coating compositions or photographic materials
11/04/2003US6642257 Agents for treating neuropathic pain
10/2003
10/30/2003WO2003088903A2 Compounds, compositions, and methods
10/30/2003US20030203938 Epothilone derivatives and their synthesis and use
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1089964B1 Hydrazine derivatives
10/28/2003US6638973 Taxane formulations
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/23/2003WO2003087093A1 Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2002096868A3 Preparation of 17-phenyl- 18, 19, 20- trinor-pgf2a and its derivatives
10/23/2003WO2001079195A9 Pyridine and pyrazine derivatives as thrombin inhibitors
10/23/2003US20030199573 2h-chromene derivatives metabolized both by cytochrome P450 and by a non-oxidative metabolic enzyme or system of enzymes; do not cause metabolic DDI when co-administered with other drugs
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030199547 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent
10/23/2003US20030199530 New compounds derived from quinazoline
10/23/2003US20030199017 Method for releasing a product comprising chemical oxidation, method for detecting said product and uses thereof
10/22/2003EP1354879A1 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1159276B1 Benzofuran-2-ones as colorants for organic materials
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1125061C C2 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125060C C-10 taxane derivatives and pharmaceutical compositions containing them
10/21/2003US6635657 Pyridine derivatives; anticoagulants
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003CA2117883C Erythromycin derivatives
10/16/2003WO2003084558A1 Improved kavalactone profile
10/16/2003WO2003084512A1 Oral delivery of a botanical
10/16/2003US20030195239 Heterocyclic esters such as 6-cyclopentyl-6-(4-phenyl-but-3-ynyl)-dihydropyran-2,4-dione, used as enzyme inhibitors or for prophylaxis of virus infections
10/16/2003US20030195208 Phthalimido derivatives and a process for their preparation
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030194785 Making an erythromycin derivative of given formula by fermenting an organism capable of producing erythromycin in the presence of a carboxylic acid of given formula
10/16/2003US20030194748 Method for labeling with tritium
10/16/2003US20030194698 E2 displacement assay for identifying inhibitors of HPV
10/16/2003CA2486480A1 Improved kavalactone profile
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1110088B1 Energy transfer dyes
10/14/2003US6632835 Antiproliferative effects against epithelial cancer cell lines and endothelial cells
10/09/2003WO2003082848A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
10/09/2003WO2003082845A1 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
10/09/2003WO2003082192A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles
10/09/2003WO2003022994A3 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/02/2003WO2003080600A1 Process to obtain dibenzylbutyrolactonic lignans; process to obtain synthetic derivatives from lignanes bearing anti-chagas chemoprophylactic and therapeutical activities
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080577A2 Amidoacetonitrile compounds
10/02/2003WO2003080573A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003WO2003080184A1 1,2-dihydropyrazol-3-ones as cytokine mediators
10/02/2003US20030187266 Non-nucleoside reverse transcriptase inhibitors
10/02/2003US20030187254 Anticholesterol agents; cardiovascular disorders; dietetics; antidiabetic agents
10/02/2003US20030187061 Antitumor agnets; antileukemia agents
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186976 Benzofurylpyrone derivatives
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003CA2477771A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003CA2477091A1 1,2-dihydropyrazol-3-ones as cytokine mediators
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347755A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
10/01/2003EP1347747A2 Method for preparing submicron particle suspensions
10/01/2003CN1445226A New cornpound derivated from quinazoline, itd preparation method and medicinal composite containig them
09/2003
09/30/2003US6627651 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human
09/30/2003US6627645 Muscarinic agonists
09/30/2003US6627611 C-glycosides and preparation of thereof as antidiabetic agents
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003US20030181514 Therapeutic compounds and methods
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/24/2003EP1346992A1 Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
09/24/2003EP1345943A2 Inhibitors of papilloma virus
09/24/2003EP1345931A2 Cysteine protease inhibitors
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 120